The Alpha-Tocopherol Beta-Carotene Study (ATBC), a project between Finland's National Public Health Institute (NPHI) and NCI, was conducted to determine whether daily supplementation with a-tocopherol, b-carotene, or both, would reduce the incidence of lung cancer or other cancers.
